Kevin has no verified overview
Kevin Schutz, PharmD
VP, Global Regulatory Affairs at CORXEL Pharmaceuticals
New York City Metropolitan Area, United States
Overview
Topics They Care About
Kevin has no verified topics they care about
Media Appearances
Kevin has no verified media appearances
Work History
2-2024
VP, Global Regulatory Affairs at CORXEL Pharmaceuticals
5-2022 - 6-2023
Vice President Regulatory Affairs at CinCor Pharma, Inc. (acquired by AstraZeneca)
6-2021 - 5-2022
Vice President Regulatory Affairs at Tiziana Life Sciences
12-2019 - 6-2021
Senior Director Regulatory Affairs at Osmotica Pharmaceutical Corp.
3-2014 - 12-2019
Senior Director, Regulatory Affairs at Insmed
9-2012 - 10-2013
Director, Regulatory Affairs at Amarin Corporation
1-2012 - 9-2012
Associate Director, Regulatory Affairs at Ipsen
3-2008 - 1-2012
Associate Director, Regulatory Affairs at EKR Therapeutics (acquired by Cornerstone Therapeutics)
3-2006 - 12-2007
Associate Director, CME and Publications at Esprit Pharma (acquired by Allergan)
3-2003 - 3-2006
Scientific Director at Embryon
2002 - 2003
Scientific Director at Ingenix
6-1997 - 6-2001
Clinical Pharmacist at Fox Chase Cancer Center
Education
1995 - 2001
PharmD from University of the Sciences in Philadelphia
2011 - 2011
Healthcare Compliance Certification Program from Seton Hall University School of Law
More Information
Social Presence :
Prographics :
Exp : 26
Location : New York City Metropolitan Area, United States
Job Level : Senior
Designation : VP, Global Regulatory Affairs at CORXEL Pharmaceuticals
